nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—PPARG—colon cancer	0.576	1	CbGaD
Pioglitazone—SLCO1B1—Irinotecan—colon cancer	0.0786	0.255	CbGbCtD
Pioglitazone—SLCO1B3—Methotrexate—colon cancer	0.0714	0.231	CbGbCtD
Pioglitazone—SLCO1B1—Methotrexate—colon cancer	0.0416	0.135	CbGbCtD
Pioglitazone—CYP2C9—Capecitabine—colon cancer	0.0375	0.122	CbGbCtD
Pioglitazone—CYP2C8—Fluorouracil—colon cancer	0.0319	0.103	CbGbCtD
Pioglitazone—CYP2C9—Fluorouracil—colon cancer	0.0223	0.0721	CbGbCtD
Pioglitazone—CYP3A4—Irinotecan—colon cancer	0.0135	0.0437	CbGbCtD
Pioglitazone—CYP3A4—Vincristine—colon cancer	0.0118	0.0382	CbGbCtD
Pioglitazone—PPARG—Topotecan—Irinotecan—colon cancer	0.0036	1	CbGdCrCtD
Pioglitazone—Rosiglitazone—PPARG—colon cancer	0.0031	1	CrCbGaD
Pioglitazone—Ischaemia—Irinotecan—colon cancer	0.00218	0.0259	CcSEcCtD
Pioglitazone—Developmental delay—Fluorouracil—colon cancer	0.002	0.0238	CcSEcCtD
Pioglitazone—Congenital anomaly—Fluorouracil—colon cancer	0.002	0.0238	CcSEcCtD
Pioglitazone—PPARG—endothelium—colon cancer	0.00195	0.0797	CbGeAlD
Pioglitazone—PPARG—blood vessel—colon cancer	0.0018	0.0735	CbGeAlD
Pioglitazone—Congenital anomaly—Capecitabine—colon cancer	0.0014	0.0167	CcSEcCtD
Pioglitazone—Developmental delay—Capecitabine—colon cancer	0.0014	0.0167	CcSEcCtD
Pioglitazone—Tooth abscess—Capecitabine—colon cancer	0.00127	0.0152	CcSEcCtD
Pioglitazone—Diabetic—Methotrexate—colon cancer	0.00118	0.0141	CcSEcCtD
Pioglitazone—SLCO1B3—vagina—colon cancer	0.00118	0.0482	CbGeAlD
Pioglitazone—PPARG—embryo—colon cancer	0.00107	0.0438	CbGeAlD
Pioglitazone—Transient ischaemic attack—Capecitabine—colon cancer	0.00105	0.0126	CcSEcCtD
Pioglitazone—PTGS1—endothelium—colon cancer	0.00104	0.0426	CbGeAlD
Pioglitazone—SLCO1B3—liver—colon cancer	0.000994	0.0406	CbGeAlD
Pioglitazone—Myocardial ischaemia—Irinotecan—colon cancer	0.000988	0.0118	CcSEcCtD
Pioglitazone—PTGS1—blood vessel—colon cancer	0.000961	0.0393	CbGeAlD
Pioglitazone—Myocardial ischaemia—Fluorouracil—colon cancer	0.000946	0.0113	CcSEcCtD
Pioglitazone—SLCO1B1—renal system—colon cancer	0.000941	0.0385	CbGeAlD
Pioglitazone—Accidental injury—Irinotecan—colon cancer	0.000897	0.0107	CcSEcCtD
Pioglitazone—Visual acuity reduced—Capecitabine—colon cancer	0.000893	0.0106	CcSEcCtD
Pioglitazone—PPARG—epithelium—colon cancer	0.000875	0.0358	CbGeAlD
Pioglitazone—PPARG—smooth muscle tissue—colon cancer	0.000843	0.0345	CbGeAlD
Pioglitazone—PPARG—renal system—colon cancer	0.000811	0.0332	CbGeAlD
Pioglitazone—SLCO1B1—digestive system—colon cancer	0.000772	0.0316	CbGeAlD
Pioglitazone—Neoplasm—Irinotecan—colon cancer	0.000718	0.00856	CcSEcCtD
Pioglitazone—Multiple fractures—Methotrexate—colon cancer	0.000681	0.00811	CcSEcCtD
Pioglitazone—Fracture—Methotrexate—colon cancer	0.000681	0.00811	CcSEcCtD
Pioglitazone—PPARG—lymphoid tissue—colon cancer	0.000674	0.0276	CbGeAlD
Pioglitazone—PPARG—digestive system—colon cancer	0.000666	0.0272	CbGeAlD
Pioglitazone—Myocardial ischaemia—Capecitabine—colon cancer	0.000661	0.00788	CcSEcCtD
Pioglitazone—Hepatic failure—Vincristine—colon cancer	0.000658	0.00785	CcSEcCtD
Pioglitazone—Polyp—Methotrexate—colon cancer	0.00065	0.00775	CcSEcCtD
Pioglitazone—Injury—Irinotecan—colon cancer	0.000627	0.00747	CcSEcCtD
Pioglitazone—PPARG—bone marrow—colon cancer	0.000614	0.0251	CbGeAlD
Pioglitazone—Visual disturbance—Irinotecan—colon cancer	0.000608	0.00725	CcSEcCtD
Pioglitazone—Proteinuria—Capecitabine—colon cancer	0.000605	0.00721	CcSEcCtD
Pioglitazone—Protein urine present—Capecitabine—colon cancer	0.000596	0.00711	CcSEcCtD
Pioglitazone—Pain in extremity—Vincristine—colon cancer	0.000592	0.00705	CcSEcCtD
Pioglitazone—Cyst—Methotrexate—colon cancer	0.000592	0.00705	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Irinotecan—colon cancer	0.000588	0.00701	CcSEcCtD
Pioglitazone—PPARG—vagina—colon cancer	0.000588	0.024	CbGeAlD
Pioglitazone—Liver disorder—Methotrexate—colon cancer	0.00058	0.00692	CcSEcCtD
Pioglitazone—SLCO1B1—liver—colon cancer	0.000575	0.0235	CbGeAlD
Pioglitazone—Cardiac failure—Fluorouracil—colon cancer	0.000566	0.00674	CcSEcCtD
Pioglitazone—CYP2C8—renal system—colon cancer	0.000535	0.0219	CbGeAlD
Pioglitazone—Fluid retention—Capecitabine—colon cancer	0.000504	0.00601	CcSEcCtD
Pioglitazone—CYP2C19—digestive system—colon cancer	0.000503	0.0206	CbGeAlD
Pioglitazone—PPARG—liver—colon cancer	0.000496	0.0203	CbGeAlD
Pioglitazone—Angina pectoris—Irinotecan—colon cancer	0.000485	0.00578	CcSEcCtD
Pioglitazone—Neoplasm—Capecitabine—colon cancer	0.00048	0.00573	CcSEcCtD
Pioglitazone—Erectile dysfunction—Vincristine—colon cancer	0.000471	0.00561	CcSEcCtD
Pioglitazone—PTGS1—epithelium—colon cancer	0.000468	0.0191	CbGeAlD
Pioglitazone—Angina pectoris—Fluorouracil—colon cancer	0.000465	0.00554	CcSEcCtD
Pioglitazone—Abnormal vision—Capecitabine—colon cancer	0.000463	0.00552	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Irinotecan—colon cancer	0.000463	0.00552	CcSEcCtD
Pioglitazone—Weight decreased—Vincristine—colon cancer	0.000463	0.00552	CcSEcCtD
Pioglitazone—PTGS1—smooth muscle tissue—colon cancer	0.000451	0.0184	CbGeAlD
Pioglitazone—Weight decreased—Irinotecan—colon cancer	0.000451	0.00537	CcSEcCtD
Pioglitazone—Proteinuria—Methotrexate—colon cancer	0.00045	0.00537	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Vincristine—colon cancer	0.00045	0.00536	CcSEcCtD
Pioglitazone—Myocardial infarction—Vincristine—colon cancer	0.000447	0.00533	CcSEcCtD
Pioglitazone—Protein urine present—Methotrexate—colon cancer	0.000444	0.00529	CcSEcCtD
Pioglitazone—CYP2C19—vagina—colon cancer	0.000444	0.0182	CbGeAlD
Pioglitazone—Diabetes mellitus—Capecitabine—colon cancer	0.000443	0.00529	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Fluorouracil—colon cancer	0.000443	0.00528	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Irinotecan—colon cancer	0.000438	0.00522	CcSEcCtD
Pioglitazone—Sweating—Vincristine—colon cancer	0.000437	0.00521	CcSEcCtD
Pioglitazone—Myocardial infarction—Irinotecan—colon cancer	0.000435	0.00519	CcSEcCtD
Pioglitazone—Gastroenteritis—Capecitabine—colon cancer	0.000435	0.00519	CcSEcCtD
Pioglitazone—PTGS1—renal system—colon cancer	0.000434	0.0177	CbGeAlD
Pioglitazone—Hepatic failure—Capecitabine—colon cancer	0.000429	0.00512	CcSEcCtD
Pioglitazone—Sweating—Irinotecan—colon cancer	0.000426	0.00508	CcSEcCtD
Pioglitazone—Infestation—Fluorouracil—colon cancer	0.000425	0.00507	CcSEcCtD
Pioglitazone—Infestation NOS—Fluorouracil—colon cancer	0.000425	0.00507	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Fluorouracil—colon cancer	0.000419	0.005	CcSEcCtD
Pioglitazone—Hepatic enzyme increased—Methotrexate—colon cancer	0.000418	0.00498	CcSEcCtD
Pioglitazone—Myocardial infarction—Fluorouracil—colon cancer	0.000417	0.00497	CcSEcCtD
Pioglitazone—Urinary tract infection—Fluorouracil—colon cancer	0.000413	0.00493	CcSEcCtD
Pioglitazone—Increased appetite—Capecitabine—colon cancer	0.000411	0.00489	CcSEcCtD
Pioglitazone—Hypoaesthesia—Vincristine—colon cancer	0.000407	0.00486	CcSEcCtD
Pioglitazone—Urinary tract disorder—Vincristine—colon cancer	0.000404	0.00482	CcSEcCtD
Pioglitazone—Connective tissue disorder—Vincristine—colon cancer	0.000402	0.0048	CcSEcCtD
Pioglitazone—Urethral disorder—Vincristine—colon cancer	0.000401	0.00478	CcSEcCtD
Pioglitazone—Sinusitis—Fluorouracil—colon cancer	0.000399	0.00476	CcSEcCtD
Pioglitazone—Cardiac failure—Capecitabine—colon cancer	0.000395	0.00471	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Capecitabine—colon cancer	0.000394	0.00469	CcSEcCtD
Pioglitazone—Connective tissue disorder—Irinotecan—colon cancer	0.000392	0.00467	CcSEcCtD
Pioglitazone—CYP2C9—digestive system—colon cancer	0.00039	0.0159	CbGeAlD
Pioglitazone—CYP2C8—vagina—colon cancer	0.000387	0.0158	CbGeAlD
Pioglitazone—Pain in extremity—Capecitabine—colon cancer	0.000386	0.0046	CcSEcCtD
Pioglitazone—Visual impairment—Irinotecan—colon cancer	0.000384	0.00458	CcSEcCtD
Pioglitazone—PPARG—lymph node—colon cancer	0.00038	0.0155	CbGeAlD
Pioglitazone—Cardiac disorder—Vincristine—colon cancer	0.00038	0.00453	CcSEcCtD
Pioglitazone—Hypoaesthesia—Fluorouracil—colon cancer	0.00038	0.00453	CcSEcCtD
Pioglitazone—Pharyngitis—Fluorouracil—colon cancer	0.000379	0.00452	CcSEcCtD
Pioglitazone—CYP2C19—liver—colon cancer	0.000375	0.0153	CbGeAlD
Pioglitazone—Cardiac disorder—Irinotecan—colon cancer	0.00037	0.00441	CcSEcCtD
Pioglitazone—Mediastinal disorder—Vincristine—colon cancer	0.000369	0.0044	CcSEcCtD
Pioglitazone—CYP3A4—renal system—colon cancer	0.000362	0.0148	CbGeAlD
Pioglitazone—Immune system disorder—Irinotecan—colon cancer	0.00036	0.00429	CcSEcCtD
Pioglitazone—Mediastinal disorder—Irinotecan—colon cancer	0.000359	0.00428	CcSEcCtD
Pioglitazone—Neoplasm—Methotrexate—colon cancer	0.000358	0.00426	CcSEcCtD
Pioglitazone—CYP2D6—renal system—colon cancer	0.000357	0.0146	CbGeAlD
Pioglitazone—Liver function test abnormal—Capecitabine—colon cancer	0.000356	0.00424	CcSEcCtD
Pioglitazone—PTGS1—digestive system—colon cancer	0.000356	0.0146	CbGeAlD
Pioglitazone—Abdominal pain upper—Capecitabine—colon cancer	0.000352	0.0042	CcSEcCtD
Pioglitazone—Pulmonary oedema—Methotrexate—colon cancer	0.000352	0.0042	CcSEcCtD
Pioglitazone—Breast disorder—Capecitabine—colon cancer	0.000349	0.00415	CcSEcCtD
Pioglitazone—Back pain—Vincristine—colon cancer	0.000345	0.00411	CcSEcCtD
Pioglitazone—Flatulence—Irinotecan—colon cancer	0.000342	0.00408	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00034	0.00405	CcSEcCtD
Pioglitazone—Back pain—Irinotecan—colon cancer	0.000336	0.004	CcSEcCtD
Pioglitazone—Muscle spasms—Irinotecan—colon cancer	0.000334	0.00398	CcSEcCtD
Pioglitazone—Influenza—Capecitabine—colon cancer	0.000333	0.00397	CcSEcCtD
Pioglitazone—Diabetes mellitus—Methotrexate—colon cancer	0.00033	0.00393	CcSEcCtD
Pioglitazone—Anaemia—Vincristine—colon cancer	0.000329	0.00393	CcSEcCtD
Pioglitazone—CYP2C8—liver—colon cancer	0.000327	0.0134	CbGeAlD
Pioglitazone—Angina pectoris—Capecitabine—colon cancer	0.000325	0.00387	CcSEcCtD
Pioglitazone—Ill-defined disorder—Irinotecan—colon cancer	0.000322	0.00384	CcSEcCtD
Pioglitazone—Anaemia—Irinotecan—colon cancer	0.000321	0.00382	CcSEcCtD
Pioglitazone—Bronchitis—Capecitabine—colon cancer	0.000321	0.00382	CcSEcCtD
Pioglitazone—Vertigo—Vincristine—colon cancer	0.00032	0.00382	CcSEcCtD
Pioglitazone—Hepatic failure—Methotrexate—colon cancer	0.000319	0.00381	CcSEcCtD
Pioglitazone—PTGS1—vagina—colon cancer	0.000314	0.0128	CbGeAlD
Pioglitazone—Malaise—Irinotecan—colon cancer	0.000313	0.00373	CcSEcCtD
Pioglitazone—Vertigo—Irinotecan—colon cancer	0.000312	0.00372	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Capecitabine—colon cancer	0.00031	0.00369	CcSEcCtD
Pioglitazone—Hypertension—Vincristine—colon cancer	0.000308	0.00367	CcSEcCtD
Pioglitazone—Anaemia—Fluorouracil—colon cancer	0.000307	0.00366	CcSEcCtD
Pioglitazone—Myalgia—Vincristine—colon cancer	0.000303	0.00362	CcSEcCtD
Pioglitazone—Weight increased—Capecitabine—colon cancer	0.000303	0.00362	CcSEcCtD
Pioglitazone—Visual disturbance—Methotrexate—colon cancer	0.000303	0.00361	CcSEcCtD
Pioglitazone—Weight decreased—Capecitabine—colon cancer	0.000302	0.0036	CcSEcCtD
Pioglitazone—Hyperglycaemia—Capecitabine—colon cancer	0.000301	0.00358	CcSEcCtD
Pioglitazone—Hypertension—Irinotecan—colon cancer	0.0003	0.00357	CcSEcCtD
Pioglitazone—Infestation—Capecitabine—colon cancer	0.000297	0.00354	CcSEcCtD
Pioglitazone—Infestation NOS—Capecitabine—colon cancer	0.000297	0.00354	CcSEcCtD
Pioglitazone—CYP3A4—digestive system—colon cancer	0.000297	0.0122	CbGeAlD
Pioglitazone—Acute coronary syndrome—Capecitabine—colon cancer	0.000293	0.00349	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Methotrexate—colon cancer	0.000293	0.00349	CcSEcCtD
Pioglitazone—CYP2D6—digestive system—colon cancer	0.000292	0.012	CbGeAlD
Pioglitazone—Discomfort—Irinotecan—colon cancer	0.000292	0.00348	CcSEcCtD
Pioglitazone—Myocardial infarction—Capecitabine—colon cancer	0.000291	0.00347	CcSEcCtD
Pioglitazone—Anaphylactic shock—Vincristine—colon cancer	0.000291	0.00347	CcSEcCtD
Pioglitazone—Oedema—Vincristine—colon cancer	0.000291	0.00347	CcSEcCtD
Pioglitazone—CYP2C9—liver—colon cancer	0.00029	0.0119	CbGeAlD
Pioglitazone—Infection—Vincristine—colon cancer	0.000289	0.00344	CcSEcCtD
Pioglitazone—Urinary tract infection—Capecitabine—colon cancer	0.000289	0.00344	CcSEcCtD
Pioglitazone—Nervous system disorder—Vincristine—colon cancer	0.000285	0.0034	CcSEcCtD
Pioglitazone—Haematuria—Capecitabine—colon cancer	0.000283	0.00338	CcSEcCtD
Pioglitazone—Oedema—Irinotecan—colon cancer	0.000283	0.00338	CcSEcCtD
Pioglitazone—Anaphylactic shock—Irinotecan—colon cancer	0.000283	0.00338	CcSEcCtD
Pioglitazone—Chest pain—Fluorouracil—colon cancer	0.000283	0.00337	CcSEcCtD
Pioglitazone—Myalgia—Fluorouracil—colon cancer	0.000283	0.00337	CcSEcCtD
Pioglitazone—Infection—Irinotecan—colon cancer	0.000281	0.00335	CcSEcCtD
Pioglitazone—Hyperhidrosis—Vincristine—colon cancer	0.000281	0.00335	CcSEcCtD
Pioglitazone—Discomfort—Fluorouracil—colon cancer	0.00028	0.00333	CcSEcCtD
Pioglitazone—Nervous system disorder—Irinotecan—colon cancer	0.000278	0.00331	CcSEcCtD
Pioglitazone—Hyperhidrosis—Irinotecan—colon cancer	0.000274	0.00326	CcSEcCtD
Pioglitazone—Anaphylactic shock—Fluorouracil—colon cancer	0.000271	0.00323	CcSEcCtD
Pioglitazone—Oedema—Fluorouracil—colon cancer	0.000271	0.00323	CcSEcCtD
Pioglitazone—Infection—Fluorouracil—colon cancer	0.000269	0.00321	CcSEcCtD
Pioglitazone—Hepatitis—Capecitabine—colon cancer	0.000267	0.00318	CcSEcCtD
Pioglitazone—Nervous system disorder—Fluorouracil—colon cancer	0.000266	0.00317	CcSEcCtD
Pioglitazone—Hypoaesthesia—Capecitabine—colon cancer	0.000265	0.00316	CcSEcCtD
Pioglitazone—Liver function test abnormal—Methotrexate—colon cancer	0.000265	0.00316	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Vincristine—colon cancer	0.000265	0.00316	CcSEcCtD
Pioglitazone—Pharyngitis—Capecitabine—colon cancer	0.000265	0.00316	CcSEcCtD
Pioglitazone—Urinary tract disorder—Capecitabine—colon cancer	0.000263	0.00314	CcSEcCtD
Pioglitazone—Insomnia—Vincristine—colon cancer	0.000263	0.00314	CcSEcCtD
Pioglitazone—Oedema peripheral—Capecitabine—colon cancer	0.000263	0.00313	CcSEcCtD
Pioglitazone—Connective tissue disorder—Capecitabine—colon cancer	0.000262	0.00313	CcSEcCtD
Pioglitazone—Urethral disorder—Capecitabine—colon cancer	0.000262	0.00312	CcSEcCtD
Pioglitazone—Breast disorder—Methotrexate—colon cancer	0.000259	0.00309	CcSEcCtD
Pioglitazone—Visual impairment—Capecitabine—colon cancer	0.000257	0.00307	CcSEcCtD
Pioglitazone—Insomnia—Irinotecan—colon cancer	0.000256	0.00305	CcSEcCtD
Pioglitazone—Dyspnoea—Irinotecan—colon cancer	0.000253	0.00301	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Vincristine—colon cancer	0.000251	0.00299	CcSEcCtD
Pioglitazone—Fatigue—Vincristine—colon cancer	0.000251	0.00299	CcSEcCtD
Pioglitazone—Eye disorder—Capecitabine—colon cancer	0.000249	0.00297	CcSEcCtD
Pioglitazone—Cardiac disorder—Capecitabine—colon cancer	0.000248	0.00295	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000247	0.00295	CcSEcCtD
Pioglitazone—Insomnia—Fluorouracil—colon cancer	0.000245	0.00292	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Irinotecan—colon cancer	0.000245	0.00291	CcSEcCtD
Pioglitazone—Fatigue—Irinotecan—colon cancer	0.000244	0.00291	CcSEcCtD
Pioglitazone—Dyspnoea—Fluorouracil—colon cancer	0.000242	0.00288	CcSEcCtD
Pioglitazone—Immune system disorder—Capecitabine—colon cancer	0.000241	0.00287	CcSEcCtD
Pioglitazone—Mediastinal disorder—Capecitabine—colon cancer	0.00024	0.00287	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000234	0.00279	CcSEcCtD
Pioglitazone—Feeling abnormal—Irinotecan—colon cancer	0.000233	0.00278	CcSEcCtD
Pioglitazone—Malnutrition—Capecitabine—colon cancer	0.000232	0.00277	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Methotrexate—colon cancer	0.000231	0.00275	CcSEcCtD
Pioglitazone—Flatulence—Capecitabine—colon cancer	0.000229	0.00273	CcSEcCtD
Pioglitazone—Erectile dysfunction—Methotrexate—colon cancer	0.000229	0.00272	CcSEcCtD
Pioglitazone—Back pain—Capecitabine—colon cancer	0.000225	0.00268	CcSEcCtD
Pioglitazone—Feeling abnormal—Fluorouracil—colon cancer	0.000224	0.00266	CcSEcCtD
Pioglitazone—Muscle spasms—Capecitabine—colon cancer	0.000223	0.00266	CcSEcCtD
Pioglitazone—CYP3A4—liver—colon cancer	0.000221	0.00905	CbGeAlD
Pioglitazone—Infestation NOS—Methotrexate—colon cancer	0.000221	0.00264	CcSEcCtD
Pioglitazone—Infestation—Methotrexate—colon cancer	0.000221	0.00264	CcSEcCtD
Pioglitazone—CYP2D6—liver—colon cancer	0.000218	0.00891	CbGeAlD
Pioglitazone—Ill-defined disorder—Capecitabine—colon cancer	0.000216	0.00257	CcSEcCtD
Pioglitazone—Urticaria—Fluorouracil—colon cancer	0.000215	0.00257	CcSEcCtD
Pioglitazone—Anaemia—Capecitabine—colon cancer	0.000215	0.00256	CcSEcCtD
Pioglitazone—Hypersensitivity—Vincristine—colon cancer	0.000214	0.00255	CcSEcCtD
Pioglitazone—Sweating—Methotrexate—colon cancer	0.000212	0.00253	CcSEcCtD
Pioglitazone—Haematuria—Methotrexate—colon cancer	0.000211	0.00251	CcSEcCtD
Pioglitazone—Malaise—Capecitabine—colon cancer	0.000209	0.0025	CcSEcCtD
Pioglitazone—Vertigo—Capecitabine—colon cancer	0.000209	0.00249	CcSEcCtD
Pioglitazone—Hypersensitivity—Irinotecan—colon cancer	0.000209	0.00249	CcSEcCtD
Pioglitazone—Asthenia—Vincristine—colon cancer	0.000209	0.00249	CcSEcCtD
Pioglitazone—PTGS1—lymph node—colon cancer	0.000203	0.00831	CbGeAlD
Pioglitazone—Asthenia—Irinotecan—colon cancer	0.000203	0.00242	CcSEcCtD
Pioglitazone—Hypertension—Capecitabine—colon cancer	0.000201	0.00239	CcSEcCtD
Pioglitazone—Hypersensitivity—Fluorouracil—colon cancer	0.0002	0.00238	CcSEcCtD
Pioglitazone—Diarrhoea—Vincristine—colon cancer	0.000199	0.00237	CcSEcCtD
Pioglitazone—Hepatitis—Methotrexate—colon cancer	0.000199	0.00237	CcSEcCtD
Pioglitazone—Myalgia—Capecitabine—colon cancer	0.000198	0.00236	CcSEcCtD
Pioglitazone—Chest pain—Capecitabine—colon cancer	0.000198	0.00236	CcSEcCtD
Pioglitazone—Arthralgia—Capecitabine—colon cancer	0.000198	0.00236	CcSEcCtD
Pioglitazone—Pharyngitis—Methotrexate—colon cancer	0.000197	0.00235	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000196	0.00234	CcSEcCtD
Pioglitazone—Urinary tract disorder—Methotrexate—colon cancer	0.000196	0.00234	CcSEcCtD
Pioglitazone—Discomfort—Capecitabine—colon cancer	0.000195	0.00233	CcSEcCtD
Pioglitazone—Urethral disorder—Methotrexate—colon cancer	0.000195	0.00232	CcSEcCtD
Pioglitazone—Diarrhoea—Irinotecan—colon cancer	0.000194	0.00231	CcSEcCtD
Pioglitazone—Dizziness—Vincristine—colon cancer	0.000192	0.00229	CcSEcCtD
Pioglitazone—Visual impairment—Methotrexate—colon cancer	0.000191	0.00228	CcSEcCtD
Pioglitazone—Oedema—Capecitabine—colon cancer	0.00019	0.00226	CcSEcCtD
Pioglitazone—Infection—Capecitabine—colon cancer	0.000188	0.00224	CcSEcCtD
Pioglitazone—Dizziness—Irinotecan—colon cancer	0.000187	0.00223	CcSEcCtD
Pioglitazone—Nervous system disorder—Capecitabine—colon cancer	0.000186	0.00222	CcSEcCtD
Pioglitazone—Eye disorder—Methotrexate—colon cancer	0.000186	0.00221	CcSEcCtD
Pioglitazone—Diarrhoea—Fluorouracil—colon cancer	0.000186	0.00221	CcSEcCtD
Pioglitazone—Cardiac disorder—Methotrexate—colon cancer	0.000184	0.0022	CcSEcCtD
Pioglitazone—Skin disorder—Capecitabine—colon cancer	0.000184	0.00219	CcSEcCtD
Pioglitazone—Hyperhidrosis—Capecitabine—colon cancer	0.000183	0.00218	CcSEcCtD
Pioglitazone—Headache—Vincristine—colon cancer	0.000182	0.00217	CcSEcCtD
Pioglitazone—Immune system disorder—Methotrexate—colon cancer	0.000179	0.00214	CcSEcCtD
Pioglitazone—Dizziness—Fluorouracil—colon cancer	0.000179	0.00214	CcSEcCtD
Pioglitazone—Mediastinal disorder—Methotrexate—colon cancer	0.000179	0.00213	CcSEcCtD
Pioglitazone—Headache—Irinotecan—colon cancer	0.000177	0.00212	CcSEcCtD
Pioglitazone—Malnutrition—Methotrexate—colon cancer	0.000173	0.00206	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000173	0.00206	CcSEcCtD
Pioglitazone—Insomnia—Capecitabine—colon cancer	0.000171	0.00204	CcSEcCtD
Pioglitazone—Headache—Fluorouracil—colon cancer	0.00017	0.00203	CcSEcCtD
Pioglitazone—Dyspnoea—Capecitabine—colon cancer	0.000169	0.00201	CcSEcCtD
Pioglitazone—Back pain—Methotrexate—colon cancer	0.000167	0.00199	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Capecitabine—colon cancer	0.000164	0.00195	CcSEcCtD
Pioglitazone—Fatigue—Capecitabine—colon cancer	0.000163	0.00195	CcSEcCtD
Pioglitazone—Ill-defined disorder—Methotrexate—colon cancer	0.00016	0.00191	CcSEcCtD
Pioglitazone—Anaemia—Methotrexate—colon cancer	0.00016	0.00191	CcSEcCtD
Pioglitazone—Feeling abnormal—Capecitabine—colon cancer	0.000156	0.00186	CcSEcCtD
Pioglitazone—Malaise—Methotrexate—colon cancer	0.000156	0.00186	CcSEcCtD
Pioglitazone—Vertigo—Methotrexate—colon cancer	0.000155	0.00185	CcSEcCtD
Pioglitazone—Urticaria—Capecitabine—colon cancer	0.000151	0.0018	CcSEcCtD
Pioglitazone—Chest pain—Methotrexate—colon cancer	0.000147	0.00175	CcSEcCtD
Pioglitazone—Myalgia—Methotrexate—colon cancer	0.000147	0.00175	CcSEcCtD
Pioglitazone—Arthralgia—Methotrexate—colon cancer	0.000147	0.00175	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000146	0.00174	CcSEcCtD
Pioglitazone—Discomfort—Methotrexate—colon cancer	0.000145	0.00173	CcSEcCtD
Pioglitazone—Anaphylactic shock—Methotrexate—colon cancer	0.000141	0.00168	CcSEcCtD
Pioglitazone—Infection—Methotrexate—colon cancer	0.00014	0.00167	CcSEcCtD
Pioglitazone—Hypersensitivity—Capecitabine—colon cancer	0.00014	0.00166	CcSEcCtD
Pioglitazone—Nervous system disorder—Methotrexate—colon cancer	0.000138	0.00165	CcSEcCtD
Pioglitazone—Skin disorder—Methotrexate—colon cancer	0.000137	0.00163	CcSEcCtD
Pioglitazone—Hyperhidrosis—Methotrexate—colon cancer	0.000136	0.00163	CcSEcCtD
Pioglitazone—Asthenia—Capecitabine—colon cancer	0.000136	0.00162	CcSEcCtD
Pioglitazone—Diarrhoea—Capecitabine—colon cancer	0.00013	0.00155	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000129	0.00153	CcSEcCtD
Pioglitazone—Insomnia—Methotrexate—colon cancer	0.000128	0.00152	CcSEcCtD
Pioglitazone—Dyspnoea—Methotrexate—colon cancer	0.000126	0.0015	CcSEcCtD
Pioglitazone—Dizziness—Capecitabine—colon cancer	0.000125	0.00149	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Methotrexate—colon cancer	0.000122	0.00145	CcSEcCtD
Pioglitazone—Fatigue—Methotrexate—colon cancer	0.000122	0.00145	CcSEcCtD
Pioglitazone—Headache—Capecitabine—colon cancer	0.000119	0.00142	CcSEcCtD
Pioglitazone—Feeling abnormal—Methotrexate—colon cancer	0.000116	0.00139	CcSEcCtD
Pioglitazone—Urticaria—Methotrexate—colon cancer	0.000112	0.00134	CcSEcCtD
Pioglitazone—Hypersensitivity—Methotrexate—colon cancer	0.000104	0.00124	CcSEcCtD
Pioglitazone—Asthenia—Methotrexate—colon cancer	0.000101	0.00121	CcSEcCtD
Pioglitazone—Diarrhoea—Methotrexate—colon cancer	9.66e-05	0.00115	CcSEcCtD
Pioglitazone—Dizziness—Methotrexate—colon cancer	9.33e-05	0.00111	CcSEcCtD
Pioglitazone—Headache—Methotrexate—colon cancer	8.84e-05	0.00105	CcSEcCtD
